Research shows transition from volume to value


Within five years, more than two thirds of all payments are expected to be based on measures of value, as payers and providers move away from fee-for-service payment, according to research commissioned by McKesson Health Solutions.

For the report The State of Value-Based Reimbursement and the Transition from Volume to Value in 2014, ORC International, a consultant specializing in research and business intelligence, interviewed executives from 114 payers and 350 providers.

From the interviews, ORC estimated the percentage of payments in fee for service, capitation, pay for performance, episodes of care/bundled payment, global payment, and other methods, such as shared savings.

ORC also used the interview results to estimate how the percentages would change in two years and in five years. Note that both payers and providers predict FFS will decline from 56% and 52% to 32% and 34%, respectively. Below are payers’ and providers’ estimates.

Mix of payment models

Payers

Providers

Source: The State of Value-Based Reimbursement and the Transition from Volume to Value in 2014, ORC International

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.

UP NEXT

Managed Care
By Peter Wehrwein
Managed Care
By Howard Wolinsky